SCHEMBL5873972

SCHEMBL5873972

C=Cc1ccc2c(c1)NC(=O)C2=CNc1ccc(CCc2ccncc2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 4/20 0.37
AKT2 P31751 1/20 0.36
MAOA P21397 1/20 0.35
MAOB P27338 1/20 0.35
MAP4K4 O95819 2/20 0.34
CDK2 P24941 2/20 0.34
IRAK4 Q9NWZ3 2/20 0.34
CDC7 O00311 1/20 0.34
ROCK2 O75116 1/20 0.34
PRKACA P17612 1/20 0.34
GSK3B P49841 1/20 0.34
CLK4 Q9HAZ1 1/20 0.34
BACE1 P56817 1/20 0.34
CSF1R P07333 4/20 0.33
TGM2 P21980 3/20 0.32
PDPK1 O15530 1/20 0.32
EGFR P00533 1/20 0.32
ERBB2 P04626 1/20 0.32
CDK1 P06493 1/20 0.32
RPS6KB1 P23443 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5419164 0.94 CSF1R (0.39) CHEK1AKT2MAP4K4CDK2IRAK4
SCHEMBL5419163 0.94 CSF1R (0.39) CHEK1AKT2MAP4K4CDK2IRAK4
SCHEMBL5419264 0.87 TGM2 (0.34) MAOAMAOBGSK3BCSF1RTGM2
SCHEMBL5419268 0.87 TGM2 (0.34) MAOAMAOBGSK3BCSF1RTGM2
SCHEMBL5873973 0.87 TGM2 (0.34) MAOAMAOBGSK3BCSF1RTGM2
SCHEMBL7704893 0.78 TGM2 (0.47) CHEK1CSF1RTGM2CDK1ALDH1A1
SCHEMBL7704891 0.78 TGM2 (0.47) CHEK1CSF1RTGM2CDK1ALDH1A1
SCHEMBL5428630 0.77 LRRK2 (0.52) GSK3BTGM2PDPK1KDM4E
SCHEMBL5428629 0.77 LRRK2 (0.52) GSK3BTGM2PDPK1KDM4E
SCHEMBL5468301 0.74 PDGFRB (0.53) CSF1RERBB2ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7129253-B2 Compounds SMITHKLINE BEECHAM CORPORATION (US) 2006-10-31 US disclosed
US-20040191210-A1 Compounds GLENNON KIMBERLEY CAROLINE (US) 2004-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040191210-A1 Compounds CDK1, AKT1, RPS6KA1 CHEK1 96/4885AKT2 28/4885MAOA 2011/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.